Munich Cluster for Systems Neurology

Breadcrumb Navigation


Press Release: SyNergy member Matthias Tschöp Awarded EMBO Membership

Prof. Dr. Matthias Tschöp, CEO of Helmholtz Zentrum München, has been elected a member of the European Molecular Biology Organization (EMBO). Today EMBO announced the names of the international scientists that have been newly elected as members based on their scientific excellence and groundbreaking research.


SyNergy member Matthias Tschöp is known for his breakthrough research in diabetes and obesity. He has revealed key elements of the gut-brain axis and its role to regulate body weight and metabolism enabling the development of several novel classes of drug candidates to prevent or reverse diabetes, obesity and metabolic diseases. He discovered that the gastric peptide ghrelin can function as a "hunger hormone" that drives appetite and food intake after food restriction. In close collaboration with Richard DiMarchi, he developed novel unimolecular combination therapeutics which show metabolic benefits in preclinical models and in early clinical trials.

Press release HZM


SyNergy-Mitglied Matthias Tschöp mit EMBO-Mitgliedschaft geehrt

Prof. Dr. Matthias Tschöp, der Wissenschaftliche Geschäftsführer des Helmholtz Zentrums München, ist zum Mitglied der European Molecular Biology Organization (EMBO) ernannt worden. Die EMBO gab heute die Namen der internationalen Wissenschaftlerinnen und Wissenschaftler bekannt, die auf der Grundlage wissenschaftlicher Exzellenz und bahnbrechender Forschung neu als Mitglieder gewählt wurden.

Pressemitteilung HZM